Insulin-like growth factor binding protein-3 inhibits the growth of non-small cell lung cancer

Cancer Research

Volumn 62, Issue 12, 2002, Pages 3530-3537

  Lee, Ho Young ^a   Chun, Kyung Hee ^a   Liu, Bingrong ^a   Wiehle, Sandra A ^a   Cristiano, Richard J ^a   Hong, Waun Ki ^a   Cohen, Pinchas ^a   Kurie, Jonathan M ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CASPASE 3; DNA FRAGMENT; GLYCOGEN SYNTHASE KINASE 3BETA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGENIC AGENT; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BCL 2; PROTEIN KINASE B; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRONCHUS MUCOSA; CANCER GROWTH; CANCER INHIBITION; CELL DEATH; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CLONOGENESIS; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOTOXICITY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ENZYME SUBSTRATE; FEMALE; FLOW CYTOMETRY; GENE DELIVERY SYSTEM; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VITRO STUDY; IN VIVO STUDY; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; TUMOR GROWTH; WESTERN BLOTTING; XENOGRAFT;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADENOVIRIDAE; ANIMALS; APOPTOSIS; CARCINOMA, NON-SMALL-CELL LUNG; CELL DIVISION; FEMALE; GENE TRANSFER TECHNIQUES; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; LUNG NEOPLASMS; MAP KINASE KINASE 1; MAP KINASE SIGNALING SYSTEM; MICE; MICE, NUDE; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT;

EID: 0037096744     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features
2. Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small cell lung cancer
3. Inhibition of the type-I insulin-like growth factor receptor expression and signaling: Novel strategies for antimetastatic therapy
4. The phosphatidylinositol 3′-kinase pathway is a dominant growth factor-activated cell survival pathway in LNCaP human prostate carcinoma cells
5. Insulin-like growth factor binding protein-3 modulates expression of Bax and Bcl-2 and potentiates p53-independent radiation-induced apoptosis in human breast cancer cells
6. Plasma levels of insulin-like growth factor-I and lung cancer risk: A case-control analysis
7. Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-β1 on programmed cell death through a p53- and IGF-independent mechanism
8. The type V transforming growth factor β receptor is the putative insulin-like growth factor binding protein 3 receptor
9. Direct functional interactions between insulin-like growth factor (IGF)binding protein-3 and retinoid X receptor-α regulate transcriptional signaling and apoptosis
10. Nuclear import of insulin-like growth factor binding protein-3 (IGFBP-3) and IGFBP-5 is mediated by the importin β subunit
11. Transforming growth factorβ-induced cell growth inhibition in human breast cancer cells is mediated through insulin-like growth factor-binding protein-3
12. Antiproliferative action of tumor necrosis factor-α on MCF-7 breast cancer cells is associated with increased insulin-like growth factor binding protein-3 accumulation
13. All-trans retinoic acid increases transforming growth factor-β2 and insulin-like growth factor binding protein-3 expression through a retinoic acid receptor-a-dependent signaling pathway
14. Estradiol and antiestrogens regulate a growth-inhibitory insulin-like growth factor binding protein-3 autocrine loop in human breast cancer cells
15. Vitamin D regulates human ectocervical epithelial cell proliferation and insulin-like growth factor binding protein-3 level
16. Induction of the growth inhibitor IGF-binding protein 3 by p53
17. Enhanced expression of dihydrofolate reductase by bovine kidney epithelial cells results in altered cell morphology, IGF-I responsiveness, and IGF binding protein-3 expression
18. Insulin-like growth factor-binding protein-3 mediates IGF-I action in bovine mammary epithelial cell line independent of an IGF interaction
19. Insulin-like growth factor (IGF) binding to cell monolayers is directly modulated by the addition of IGF-binding proteins
20. Plasminogen binds the heparin-binding domain of insulin-like growth factor-binding protein-3
21. All-trans retinoic acid converts E2F into a transcriptional suppressor and inhibits the growth of human bronchial epithelial cells through a retinoic acid receptor-dependent signaling pathway
22. Insulin-like growth factor binding protein-6 inhibits the growth of human bronchial epithelial cells and increases in abundance with all-trans retinoic acid treatment
23. Insulin-like growth factor binding protein-6 activates programmed cell death in non-small cell lung cancer cells
24. All-trans retinoic acid inhibits Jun-N-terminal kinase-dependent signaling pathway
25. High efficiency gene transfer and high-level expression of wild-type p53 in human lung cancer cells mediated by recombinant adenovirus
26. The IGF-I receptor in cancer research
27. Antitumor effects of an adenovirus expressing antisense insulin-like growth factor I receptor on human lung cancer cell lines
28. Role of insulin-like growth factors and their binding proteins in growth and carcinogenesis
29. Autocrine function for insulin-like growth factor-I and response to exogenous IGF-I in small cell lung cancer cell lines and fresh tumor cells
30. Characterization of insulin-like growth factor-I receptors and growth effects in human lung cancer cell lines
31. Evidence for autocrine mitogenic stimulation by somatomedin-C/insulin-like growth factor-I on an established human lung cancer cell line
32. Transfection of human insulin-like growth factor-binding protein-3 gene inhibits cell growth and tumorigenicity: A cell culture model for lung cancer
33. Phosphatidylinositol-3 kinase dependent pathways: The role in control of cell growth, survival, and malignant transformation
34. Increased p53-dependent apoptosis by the insulin-like growth factor binding protein IGFBP-3 in human colonic adenoma derived cells
35. Akt/Protein Kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation
36. Akt/protein kinase B inhibits cell death by preventing the release of cytochrome c from mitochondria
37. Suppression of transforming growth factor-β-induced apoptosis through a phosphatidylinositol 3-kinase/Akt-dependent pathway
38. Protection of CD95-mediated apoptosis by activation of phosphatidylinositide 3-kinase and protein kinase B
39. Akt-dependent and -independent survival signaling pathways utilized by insulin-like growth factor I